THYROID EYE DISEASE

This study is testing an investigational drug called Lu AG22515 to see if it can reduce eye bulging in people with moderate-to-severe Thyroid Eye Disease. It follows 20 adults for 24 weeks to measure changes in eye protrusion and track how the drug moves through the body. The goa…

This study is testing whether satralizumab, an injected medication, can help people with moderate-to-severe thyroid eye disease. It will measure if the drug reduces eye bulging, double vision, pain, and inflammation compared to a placebo. The goal is to control the disease and im…

This study is testing whether satralizumab, an injectable medication, can help control moderate-to-severe thyroid eye disease. About 131 participants will receive either the drug or a placebo to see if it reduces eye bulging, double vision, pain, and improves quality of life. The…

This study is testing whether VRDN-003 injections are safe and how the body processes the drug in people with thyroid eye disease. Participants receive injections every 4 or 8 weeks and researchers monitor for side effects. The trial includes 87 adults with thyroid eye disease wh…

This study is testing whether regular injections of an experimental drug called VRDN-003 can help people with active Thyroid Eye Disease. About 117 participants will receive either the drug or a placebo injection every 4 or 8 weeks to see if it reduces eye bulging, inflammation, …

This study continues research on batoclimab for thyroid eye disease in people who finished earlier trials. It has two parts: one observes how long eye improvements last without treatment, while the other gives batoclimab to measure its effectiveness. The study involves 180 partic…

This study is testing whether weekly injections of an experimental drug called batoclimab can reduce eye bulging and inflammation in people with active Thyroid Eye Disease. About 100 participants will receive either the drug or a placebo for 24 weeks to see which is better at pul…

This Phase 3 trial is testing whether an injectable medication called teprotumumab can reduce eye bulging and other symptoms in people with active, moderate-to-severe Thyroid Eye Disease. The study involves 89 participants who receive either the drug or a placebo injection to com…

This study is testing whether regular injections of an investigational drug called VRDN-003 can help control chronic Thyroid Eye Disease. About 195 participants with moderate to severe symptoms will receive either the drug or a placebo injection every 4 or 8 weeks. Researchers wi…